|
63
|
214
|
1m6dA |
Crystal structure of human cathepsin f |
|
96
|
320
|
1kxrA |
Crystal structure of calcium-bound protease core of calpain i |
|
155
|
699
|
1kfuL |
Crystal structure of human m-calpain form ii |
|
73
|
212
|
1khqA |
Orthorhombic form of papain/zlfg-dam covalent complex |
|
143
|
699
|
1kfxL |
Crystal structure of human m-calpain form i |
|
70
|
212
|
1khpA |
Monoclinic form of papain/zlfg-dam covalent complex |
|
43
|
164
|
1k3bB |
Crystal structure of human dipeptidyl peptidase i (cathepsin c): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases |
|
100
|
438
|
1jqpA |
Dipeptidyl peptidase i (cathepsin c), a tetrameric cysteine protease of the papain family |
|
49
|
205
|
1hucB |
The refined 2.15 angstroms x-ray crystal structure of human liver cathepsin b: the structural basis for its specificity |
|
46
|
175
|
1icfA |
Crystal structure of mhc class ii associated p41 ii fragment in complex with cathepsin l |
|
77
|
254
|
1gmyA |
Cathepsin b complexed with dipeptidyl nitrile inhibitor |
|
65
|
216
|
1gecE |
Glycyl endopeptidase-complex with benzyloxycarbonyl-leucine-valine-glycine-methylene covalently bound to cysteine 25 |
|
72
|
217
|
1gloA |
Crystal structure of cys25ser mutant of human cathepsin s |
|
151
|
452
|
1gcbA |
Gal6, yeast bleomycin hydrolase dna-binding protease (thiol) |
|
64
|
215
|
1f29A |
Crystal structure analysis of cruzain bound to a vinyl sulfone derived inhibitor (i) |
|
63
|
215
|
1ewmA |
The cysteine protease cruzain bound to wrr-112 |
|
65
|
215
|
1f2aA |
Crystal structure analysis of cruzain bound to a vinyl sulfone derived inhibitor (ii) |
|
66
|
215
|
1f2bA |
Crystal structure analysis of cruzain bound to vinyl sulfone derived inhibitor (iii) |
|
63
|
215
|
1ewlA |
Crystal structure of cruzain bound to wrr-99 |
|
68
|
221
|
1fh0A |
Crystal structure of human cathepsin v complexed with an irreversible vinyl sulfone inhibitor |
|
67
|
215
|
1ewpA |
Cruzain bound to mor-leu-hpq |
|
64
|
215
|
1f2cA |
Crystal structure analysis of cryzain bound to vinyl sulfone derived inhibitor (iv) |
|
69
|
215
|
1ewoA |
The cysteine protease cruzain bound to wrr-204 |
|
75
|
242
|
1ef7A |
Crystal structure of human cathepsin x |
|
74
|
275
|
1deuA |
Crystal structure of human procathepsin x: a cysteine protease with the proregion covalently linked to the active site cysteine |
|
70
|
335
|
1dkiA |
Crystal structure of the zymogen form of streptococcal pyrogenic exotoxin b active site (c47s) mutant |
|
164
|
699
|
1df0A |
Crystal structure of m-calpain |
|
46
|
205
|
1csbB |
Crystal structure of cathepsin b inhibited with ca030 at 2.1 angstroms resolution: a basis for the design of specific epoxysuccinyl inhibitors |
|
55
|
173
|
1cv8A |
Staphopain, cysteine proteinase from staphylococcus aureus v8 |
|
72
|
253
|
1cpjA |
Crystal structures of recombinant rat cathepsin b and a cathepsin b-inhibitor complex: implications for structure-based inhibitor design |
|
63
|
316
|
1cs8A |
Crystal structure of procathepsin l |
|
69
|
253
|
1cteA |
Crystal structures of recombinant rat cathepsin b and a cathepsin b-inhibitor complex: implications for structure-based inhibitor design |
|
68
|
212
|
1cvzA |
Crystal structure analysis of papain with clik148(cathepsin l specific inhibitor) |
|
60
|
312
|
1cjlA |
Crystal structure of a cysteine protease proform |
|
64
|
216
|
1cqdA |
The 2.1 angstrom structure of a cysteine protease with proline specificity from ginger rhizome, zingiber officinale |
|
166
|
453
|
1cb5A |
Human bleomycin hydrolase. |
|
62
|
212
|
1bqiA |
Use of papain as a model for the structure-based design of cathepsin k inhibitors. crystal structures of two papain inhibitor complexes demonstrate binding to s'-subsites. |
|
66
|
212
|
1bp4A |
Use of papain as a model for the structure-based design of cathepsin k inhibitors. crystal structures of two papain inhibitor complexes demonstrate binding to s'-subsites. |
|
82
|
310
|
1by8A |
The crystal structure of human procathepsin k |
|
67
|
215
|
1iwdA |
Proposed amino acid sequence and the 1.63 angstrom x-ray crystal structure of a plant cysteine protease ervatamin b: insight into the structural basis of its stability and substrate specificity. |
|
60
|
215
|
1au3A |
Crystal structure of the cysteine protease human cathepsin k in complex with a covalent pyrrolidinone inhibitor |
|
56
|
215
|
1au4A |
Crystal structure of the cysteine protease human cathepsin k in complex with a covalent pyrrolidinone inhibitor |
|
68
|
215
|
1ayuA |
Crystal structure of cysteine protease human cathepsin k in complex with a covalent symmetric biscarbohydrazide inhibitor |
|
76
|
253
|
1itoA |
Crystal structure analysis of bovine spleen cathepsin b-e64c complex |
|
59
|
215
|
1au0A |
Crystal structure of the cysteine protease human cathepsin k in complex with a covalent symmetric diacylaminomethyl ketone inhibitor |
|
61
|
215
|
1ayvA |
Crystal structure of cysteine protease human cathepsin k in complex with a covalent thiazolhydrazide inhibitor |
|
66
|
215
|
1atkA |
Crystal structure of the cysteine protease human cathepsin k in complex with the covalent inhibitor e-64 |
|
65
|
215
|
1bgoA |
Crystal structure of cysteine protease human cathepsin k in complex with a covalent peptidomimetic inhibitor |
|
55
|
215
|
1au2A |
Crystal structure of the cysteine protease human cathepsin k in complex with a covalent propanone inhibitor |
|
57
|
215
|
1aywA |
Crystal structure of cysteine protease human cathepsin k in complex with a covalent benzyloxybenzoylcarbohydrazide inhibitor |
